AzTrials
AzTrials

Cervical PainTIPIC-UNVNCT03804112

TransIent Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome: Clinical and Radiological Follow-up

An observational study of Cervical Pain and Vasculitis, run by Fondation Ophtalmologique Adolphe de Rothschild at 6 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

TIPIC syndrome (previously called carotidynia) is a rare entity of unknown cause, where the patient has a temporary cervical pain associated with a suggestive inflammation around the carotid artery. Usually considered as a unique and benign episode, some patients have recurrences and the follow-up is usually short. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cervical Pain, Vasculitis
What is being tested?
Ultrasound exam with Doppler and Blood samples
How many people
47 participants
Where
6 sitesFrance
Study dates
17 Dec 2018to 18 Feb 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: all patient previously identified with a TIPC syndrom

Who may be able to join

  • Patients with at least one episode of TIPIC syndrome for more than 12 months

Who cannot join

None listed.

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

France6 sites
  • CHU de Montpellier

    Montpellier, 34295

  • Hôpital Pitié Salpêtrière

    Paris, 75013

  • Centre Hospitalier de Saint-Anne

    Paris, 75014

  • Fondation Ophtalmologique A. de Rothschild

    Paris, 75019

  • CHU de Toulouse

    Toulouse, 31059

  • CHU de TOURS

    Tours, 37044

Other trials in France

About this study

TIPIC syndrome (previously called carotidynia) is a rare entity of unknown cause, where the patient has a temporary cervical pain associated with a suggestive inflammation around the carotid artery. Usually considered as a unique and benign episode, some patients have recurrences and the follow-up is usually short. In this study the investigators aim to evaluate patients who presented a TIPIC episode at least 3 months before, clinically and with a cervical doppler ultrasound

Being tested
Ultrasound exam with Doppler, Blood samples
Medical subject headings
Neck Pain, Vasculitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound exam with DopplerDiagnostic test

    Ultrasound exam of the neck to search a perivascular inflammation at the level of the carotid bifurcation.

  • Blood samplesBiological

    blood count , CRP and viral serologies (herpes virus, chlamydia, mycoplasma),

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assess the incidence of recurrence of TIPIC syndrome after a first episode

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2019
  2. Study start17 Dec 2018
  3. Primary completion18 Feb 2020
  4. Study completion18 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
47 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03804112
Sponsor's protocol ID
MOA_2018_2
Acronym
TIPIC-UNV
Status last verified
Jun 2021
First submitted
11 Jan 2019
Last updated
22 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Obadia M, Nasr N, Volle G, Charbonneau F, Guillaume J, Naggara O, Sadik JC, Lecler A. Long-term clinical and ultrasound follow-up after transient perivascular inflammation of the carotid artery (TIPIC) syndrome: a multicenter study. Cephalalgia. 2024 Feb;44(2):3331024241230247. doi: 10.1177/03331024241230247.

    PubMed 38318645

Questions about this trial

What is this clinical trial studying?

An observational study of Cervical Pain and Vasculitis, run by Fondation Ophtalmologique Adolphe de Rothschild at 6 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assess the incidence of recurrence of TIPIC syndrome after a first episode (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03804112, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in